Trustees’ Annual Report for the period From: 1 April 2024 To: 31 March 2025
Charity name: The Battle Cancer Program
Charity registration number: 1193909
Objectives and Activities - Charitable purposes (as set out in the governing document)The preservation and promotion of good health by providing tailored functional fitness programs and peer-to-peer community support for individuals in any part of the world affected by ill-health, in particular but not limited to those who have had cancer treatment, as a path to rebuilding physical and mental strength.
Main activities in relation to these purposes for the public benefitDuring 2024/25, the charity continued to deliver structured 12-week functional fitness programmes through partner gyms, supporting people affected by cancer to rebuild strength, confidence, and wellbeing in a supportive community environment. Programmes combine physical training, peer support and celebration events that integrate participants into the wider Battle Cancer community.The charity also focused on strengthening its fundraising model, embedding programme-linked fundraising events and growing donor support to create a more sustainable financial base for delivery.
Public benefit statement - The trustees confirm that they have had due regard to the Charity Commission’s guidance on public benefit when planning activities and setting the charity’s objectives. Contribution made by volunteersVolunteers continue to support the charity by promoting the programme at events, assisting at community activities, and helping create welcoming environments within gyms. Their contribution increases reach and reduces delivery costs.
Achievements and Performance 2024/25 represented a significant year of growth and consolidation for the charity. Key achievements include: Continued delivery of the 12-week Battle Cancer Program in multiple gym locations, supporting individuals affected by cancer to improve physical and mental wellbeing. Further embedding of programme-linked events and community fundraising as part of the participant journey.Increased financial stability through substantial growth in income, enabling the charity to strengthen staffing capacity and programme infrastructure. Ongoing development of governance, financial oversight, and operational systems as activity levels increased.The charity’s work continues to make a meaningful difference to participants by improving health outcomes, reducing isolation, and helping individuals regain confidence after treatment.
Achievements against objectives The charity maintained programme delivery across numerous locations and continued to support a large cohort of participants through structured exercise and community support.
Performance of fundraising activities Fundraising performance improved significantly during the year. Income from donations and legacies rose to £192,132, more than doubling the prior year. This reflects strengthened fundraising activity, increased community engagement, and the
integration of fundraising within programme delivery. Investment performanceThe charity does not hold financial investments. Funds are applied directly to programme delivery, staffing and operational support.
Financial Review Financial position Total income (turnover) for the year was £192,132 (2024: £89,875).Cost of sales amounted to £21,097, resulting in a gross profit of £171,035. Administrative and operating expenditure totalled £64,750.The charity recorded an operating surplus of £106,285 for the year.
Reserves policyReserves are held to protect the charity against fluctuations in fundraising income and to ensure continuity of programme delivery and staffing. Reserves held At 31 March 2025, retained reserves stood at £192,166 (2024: £85,881). This significant increase reflects the surplus generated during the year and places the charity in a stronger position to manage risk, invest in delivery, and support future growth. Going concernThe trustees have reviewed forecasts and current financial performance and have no material concerns regarding the charity’s ability to continue as a going concern.
Principal risks The main risks facing the charity include: Potential reduction in fundraising income Reliance on continued engagement from gym partners Rising delivery and staffing costs as the programme grows Trustees manage these risks through income diversification, careful cost monitoring, and strengthening long-term partnerships. Structure, Governance and ManagementGoverning documentThe charity is governed by its constitution.Constitution The Battle Cancer Program is a Charitable Incorporated Organisation (CIO).
Trustee appointment Trustees are appointed in accordance with the provisions of the constitution.Induction and training of trusteesTrustees are supported through regular meetings, financial reporting, and guidance on their roles and responsibilities.Organisational structure
The charity is overseen by the Board of Trustees. Day-to-day activity is supported by employed staff (average of two during the year), programme coaches, and volunteers.
Details Charity name: The Battle Cancer Program
Other name: The BCPRegistered charity number: 1193909 Principal address:1–3 Finnimore Industrial EstateOttery St MaryEX11 1NR
Chairman: Mr S Britton
Trustees during the year:Scott Britton, Freya Britton, Turlough Adley, James Dollar, Hywel Thomas, Robert Rich
Registration number: 1193909
The Battle Cancer Program
Annual Report and Unaudited Financial Statements
for the Year Ended 31 March 2025
Kneeshaws Chartered Accountants Fourth Floor St James House St James's Row Burnley Lancashire BB11 1DR
The Battle Cancer Program
Contents
| Company Information | 1 |
|---|---|
| Profit and Loss Account and Statement of Retained Earnings | 2 |
| Balance Sheet | 3 |
| Notes to the Unaudited Financial Statements | 4 to 6 |
| Detailed Profit and Loss Account | 7 to 8 |
The Battle Cancer Program
Company Information
Chairman Mr S Britton Registered office 1-3 Finnimore Industrial Estate Ottery St Mary EX11 1NR Accountants Kneeshaws Chartered Accountants Fourth Floor St James House St James's Row Burnley Lancashire BB11 1DR
Page 1
The Battle Cancer Program
Profit and Loss Account and Statement of Retained Earnings for the Year Ended 31 March 2025
| Note Turnover Cost of sales Gross profit Administrative expenses Operating profit Profit before tax 4 Profit for the financial year Retained earnings brought forward Retained earnings carried forward |
2025 £ 192,132 (21,097) 171,035 (64,750) 106,285 106,285 106,285 85,881 192,166 |
2024 £ 89,875 (9,872) |
|---|---|---|
| 80,003 (55,101) |
||
| 24,902 | ||
| 24,902 | ||
| 24,902 60,979 |
||
| 85,881 |
The notes on pages 4 to 6 form an integral part of these financial statements. Page 2
The Battle Cancer Program
(Registration number: 1193909) Balance Sheet as at 31 March 2025
| Note Fixed assets Tangible assets 5 Current assets Stocks 6 Debtors Cash at bank and in hand Creditors: Amounts falling due within one year 7 Net current assets Net assets Capital and reserves Retained earnings Shareholders' funds |
2025 £ 3,326 5,455 1,871 190,691 198,017 (9,177) 188,840 192,166 192,166 192,166 |
2024 £ 4,432 17,277 - 73,217 |
|---|---|---|
| 90,494 (9,045) |
||
| 81,449 | ||
| 85,881 | ||
| 85,881 | ||
| 85,881 |
For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.
Approved and authorised by the Board on 30 January 2026 and signed on its behalf by:
......................................... Mr S Britton Chairman
The notes on pages 4 to 6 form an integral part of these financial statements. Page 3
The Battle Cancer Program
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025
1 General information
The company is a Charitable incorporated organisation, incorporated in England and Wales.
The address of its registered office is: 1-3 Finnimore Industrial Estate Ottery St Mary EX11 1NR
These financial statements were authorised for issue by the Board on 30 January 2026.
2 Accounting policies
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.
Tangible assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class
Office equipment
Depreciation method and rate
25% per annum reducing balance basis
Page 4
The Battle Cancer Program
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Defined contribution pension obligation
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.
3 Staff numbers
The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).
4 Profit before tax
Arrived at after charging/(crediting)
Page 5
The Battle Cancer Program
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025
| Depreciation expense 5 Tangible assets Cost At 1 April 2024 At 31 March 2025 Depreciation At 1 April 2024 Charge for the year At 31 March 2025 Net book value At 31 March 2025 At 31 March 2024 6 Stocks Stock 7 Creditors Creditors: amounts falling due within one year Due within one year Taxation and social security Accruals and deferred income Other creditors |
2025 £ 1,107 Office equipment £ 6,690 |
2024 £ 1,198 |
||
|---|---|---|---|---|
| Total £ 6,690 6,690 2,258 1,106 3,364 3,326 4,432 2024 £ 17,277 |
||||
| 6,690 | ||||
| 2,258 1,106 |
||||
| 3,364 | ||||
| 3,326 | ||||
| 4,432 | ||||
| 2025 £ 5,455 2025 £ 2,337 840 6,000 9,177 |
||||
| 2024 £ 2,205 840 6,000 |
||||
| 9,045 |
Page 6
The Battle Cancer Program
Detailed Profit and Loss Account for the Year Ended 31 March 2025
| Turnover (analysed below) Cost of sales (analysed below) Gross profit Gross profit (%) Administrative expenses Employment costs (analysed below) Establishment costs (analysed below) General administrative expenses (analysed below) Finance charges (analysed below) Depreciation costs (analysed below) Operating profit Profit before tax |
2025 £ 192,132 (21,097) 171,035 89.02% (50,469) (3,250) (9,864) (60) (1,107) (64,750) 106,285 106,285 |
2024 £ 89,875 (9,872) |
|---|---|---|
| 80,003 | ||
| 89.02% (39,260) (2,750) (11,833) (60) (1,198) |
||
| (55,101) | ||
| 24,902 | ||
| 24,902 |
This page does not form part of the statutory financial statements. Page 7
The Battle Cancer Program
Detailed Profit and Loss Account for the Year Ended 31 March 2025
| Turnover Donations and legacies Cost of sales Opening raw materials Direct costs Closing raw materials Employment costs Wages and salaries (excluding directors) Staff NIC (Employers) Staff pensions (Defined contribution) Program coach Establishment costs Rent General administrative expenses Computer software and maintenance costs Printing, postage and stationery Trade subscriptions Sundry expenses Travel and subsistence Advertising Accountancy fees Consultancy fees Finance charges Bank charges Depreciation costs Depreciation of office equipment (owned) |
2025 £ 192,132 17,277 9,275 (5,455) 21,097 43,880 3,547 702 2,340 50,469 3,250 1,075 534 561 - 2,412 1,384 1,200 2,698 9,864 60 1,107 |
2024 £ 89,875 |
|---|---|---|
| 16,510 10,639 (17,277) |
||
| 9,872 | ||
| 30,595 2,471 622 5,572 |
||
| 39,260 | ||
| 2,750 | ||
| 70 290 273 515 2,682 4,834 840 2,329 |
||
| 11,833 | ||
| 60 | ||
| 1,198 |
This page does not form part of the statutory financial statements. Page 8
CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Independent Examiner's Report Report to the trusteesl mombers of The Battle Cancer Program On accounts for the year ended 31¥1 March 2025 Charity no (if any) 1193909 Set out on pages 1108 I report to the trustees on my examination of the accounts of the above charily I'the Trusf'l for the year ended 3110312025. Rosponsibilities and As the charity trustees of the Trust, you are responsible for the preparation basls of report of Ihe accounts in accordance wlth Ihe requirements of the Charities Act 20111"the Act'}. I report In respect of my examination of the Trust's accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 14515llbl of the Act. I have completed my examination. I confirm that no material mallers have come lo my attention (other than Ihal disclosed below ') in connection with the examination which gives me Gause lo believe that in, any material respect.. accounting records were not kept in accordance with section 130 of the Act or the accounts do not accord with the accounting records Independent examiner's statement I have no concerns and have come across no other matters in Connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts lo be reached. Please delete the words in Ihe brackets if they do not apply. Signed: Date: 3ra Name: Andrew James Davies Relevant profossional qualificationls) or body (Sf any): BFP FCA {ICAEW} Addyoss: Fourth Floor St James House Sl James's Row Burnley BB11 1 DR IER October 2018
Section B Disclosure Only complete if the examiner needs to highlight malters of concern (see CC32, Independent examination of charity accounts.. directions and guidance for examiners). Glve here brief details of any items that the examiner wishes to disclose. IER October 2018